These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36348013)

  • 1. Short stature in PRMT7 Mutations: first evidence of response to growth hormone treatment.
    Rodari G; Villa R; Porro M; Gangi S; Iascone M; Elli F; Giacchetti F; Profka E; Collini V; Dall'Antonia A; Arosio M; Mantovani G; Bedeschi MF; Giavoli C
    Eur J Hum Genet; 2023 Feb; 31(2):195-201. PubMed ID: 36348013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further delineation of the phenotype caused by loss of function mutations in PRMT7.
    Valenzuela I; Segura-Puimedon M; Rodríguez-Santiago B; Fernández-Alvarez P; Vendrell T; Armengol L; Tizzano E
    Eur J Med Genet; 2019 Mar; 62(3):182-185. PubMed ID: 30006058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the clinical and molecular spectrum of PRMT7 mutations: 3 additional patients and review.
    Agolini E; Dentici ML; Bellacchio E; Alesi V; Radio FC; Torella A; Musacchia F; Tartaglia M; Dallapiccola B; Nigro V; Digilio MC; Novelli A
    Clin Genet; 2018 Mar; 93(3):675-681. PubMed ID: 28902392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities.
    Cali E; Suri M; Scala M; Ferla MP; Alavi S; Faqeih EA; Bijlsma EK; Wigby KM; Baralle D; Mehrjardi MYV; Schwab J; Platzer K; Steindl K; Hashem M; Jones M; Niyazov DM; Jacober J; Littlejohn RO; Weis D; Zadeh N; Rodan L; Goldenberg A; Lecoquierre F; Dutra-Clarke M; Horvath G; Young D; Orenstein N; Bawazeer S; Vulto-van Silfhout AT; Herenger Y; Dehghani M; Seyedhassani SM; Bahreini A; Nasab ME; Ercan-Sencicek AG; Firoozfar Z; Movahedinia M; Efthymiou S; Striano P; Karimiani EG; Salpietro V; Taylor JC; Redman M; Stegmann APA; Laner A; Abdel-Salam G; Li M; Bengala M; Müller AJ; Digilio MC; Rauch A; Gunel M; Titheradge H; Schweitzer DN; Kraus A; Valenzuela I; McLean SD; Phornphutkul C; Salih M; Begtrup A; Schnur RE; Torti E; Haack TB; Prada CE; Alkuraya FS; Houlden H; Maroofian R
    Genet Med; 2023 Jan; 25(1):135-142. PubMed ID: 36399134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal and postnatal presentation of PRMT7 related syndrome: Expanding the phenotypic manifestations.
    Birnbaum R; Yosha-Orpaz N; Yanoov-Sharav M; Kidron D; Gur H; Yosovich K; Lerman-Sagie T; Malinger G; Lev D
    Am J Med Genet A; 2019 Jan; 179(1):78-84. PubMed ID: 30513135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel PRMT7 mutation in a rare case of dysmorphism and intellectual disability.
    Poquérusse J; Whitford W; Taylor J; Alburaiky S; Snell RG; Lehnert K; Jacobsen JC
    J Hum Genet; 2022 Jan; 67(1):19-26. PubMed ID: 34244600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the arginine methyltranserase PRMT7 causes syndromic intellectual disability with microcephaly and brachydactyly.
    Kernohan KD; McBride A; Xi Y; Martin N; Schwartzentruber J; Dyment DA; Majewski J; Blaser S; ; Boycott KM; Chitayat D
    Clin Genet; 2017 May; 91(5):708-716. PubMed ID: 27718516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
    Ertl DA; de Nanclares GP; Jüppner H; Hanna P; Pagnano A; Pereda A; Rothenbuhler A; Del Sindaco G; Ruiz-Cuevas P; Audrain C; Escribano A; Berkenou J; Gleiss A; Mantovani G; Linglart A
    Eur J Endocrinol; 2023 Jul; 189(1):123-131. PubMed ID: 37440712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis and growth hormone response in patients with syndromic short stature.
    Sun H; Li N; Wan N
    BMC Med Genomics; 2021 Nov; 14(1):261. PubMed ID: 34740356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of bone health index as a measure of bone health in short-statured children before and during treatment with recombinant growth hormone.
    Holzapfel L; Choukair D; Schenk JP; Bettendorf M
    J Pediatr Endocrinol Metab; 2023 Sep; 36(9):824-831. PubMed ID: 37531076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Mutations in the GH/IGF Axis.
    Domené S; Domené HM
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):39-62. PubMed ID: 30378782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated growth hormone deficiency in children with vertically transmitted short stature: What do the genes tell us?
    Plachy L; Amaratunga SA; Dusatkova P; Maratova K; Neuman V; Petruzelkova L; Zemkova D; Obermannova B; Snajderova M; Kolouskova S; Sumnik Z; Lebl J; Pruhova S
    Front Endocrinol (Lausanne); 2022; 13():1102968. PubMed ID: 36714562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone therapy in childhood-onset growth hormone deficiency: adult anthropometric and psychological outcomes.
    Sandberg DE; MacGillivray MH
    Endocrine; 2000 Apr; 12(2):173-82. PubMed ID: 10905377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial empty sella syndrome, GH deficiency and transient central adrenal insufficiency in a patient with NF1.
    Kyritsi EM; Hasiotou M; Kanaka-Gantenbein C
    Endocrine; 2020 Aug; 69(2):377-385. PubMed ID: 32519328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency.
    Perez-Colon S; Lazareva O; Purushothaman R; Malik S; Ten S; Bhangoo A
    Int J Endocrinol Metab; 2018 Jul; 16(3):e58928. PubMed ID: 30197657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone improves short stature in children with Shwachman-Diamond syndrome.
    Bogusz-Wójcik A; Kołodziejczyk H; Moszczyńska E; Klaudel-Dreszler M; Oracz G; Pawłowska J; Szalecki M
    Pediatr Endocrinol Diabetes Metab; 2021; 27(2):87-92. PubMed ID: 33878854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty.
    Çetinkaya S; Poyrazoğlu Ş; Baş F; Ercan O; Yıldız M; Adal E; Bereket A; Abalı S; Aycan Z; Erdeve ŞS; Berberoğlu M; Şıklar Z; Tayfun M; Darcan Ş; Mengen E; Bircan İ; Jones FMÇ; Şimşek E; Papatya ED; Özbek MN; Bolu S; Abacı A; Büyükinan M; Darendeliler F
    J Pediatr Endocrinol Metab; 2018 Jan; 31(2):175-184. PubMed ID: 29353264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.